JEM vs TSLA

JEM exhibits a Piotroski F-Score of 4/9, indicating a stable but mediocre financial health baseline, yet this is overshadowed by catastrophic price performance and operational failure. The company has suffered a 97.1% decline over the last year, crashing from a 52-week high of $158.00 to $0.11. While the balance sheet shows low leverage (Debt/Equity 0.08) and decent liquidity (Current Ratio 2.81), the core business is hemorrhaging cash with an operating margin of -71.57% and a devastating ROE of -133.41%. The lack of an Altman Z-Score and Graham Number reflects the absence of positive earnings, rendering traditional value metrics inapplicable.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.